|
[1] Smith J, Grizot S, Arnould S, et al. A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Res, 2006, 34(22): e149-e149.
[2] Menoret S, Fontaniere S, Jantz D, et al. Generation of Ragl-knockout immunodeficient rats and mice using engineered meganucleases. FASEB J, 2013, 27( 2) :703-711.
[3] Kim Y G, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA, 1996, 93(3): 1156-1160
[4] Break through of the year. The runners-up. Science, 2012, 338(6114): 1525-1532
[5] Mussolino C, Cathomen T. RNA guides genome engineering. Nat Biotechnol, 2013, 31(3): 208-209
[6] Hopkins C M, White F F, Choi S H, et al. Identification of a family of avirulence genes from Xanthomonas oryzae pv. oryzae. Mol. Plant-Microbe Interact, 1992, 5(6): 451-459.
[7] Bonas U, Stall R E, Staskawicz B. Genetic and structural characterization of the avirulence gene avrBs3 from Xanthomonas campestris pv. vesicatoria. Mol Gen Genet, 1989, 218(1): 127-136.
[8] Kay S, Hahn S, Marois E, et al. A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science, 2007, 318(5850): 648-651.
[9] Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors. Science, 2009, 326(5959): 1509-1512.
[10] Moscou M J, Bogdanove A J. A simple cipher governs DNA recognition by TAL effectors. Science, 2009, 326(5959): 1501-1501.
[11] Deng D, Yan C, Pan X, et al. Structural basis for sequence-specific recognition of DNA by TAL effectors. Science, 2012, 335(6069): 720-723.
[12] Mak A N S, Bradley P, Cernadas R A, et al. The crystal structure of TAL effector PthXo1 bound to its DNA target. Science, 2012, 335(6069): 716-719.
[13] Chen K, Gao C. TALENs: Customizable molecular DNA scissors for genome engineering of plants. J Genet Genomics, 2013, 40(6): 271-279.
[14] McMahon M A, Rahdar M, Porteus M. Gene editing: not just for translation anymore. Nat Methods, 2011, 9(1):28-31.
[15] Cermak T, Doyle E L, Christian M, et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res, 2011, 39(12): e82-e82.
[16] Grau J, Boch J, Posch S. TALENoffer: genome-wide TALEN off-target prediction. Bioinformatics, 2013, 29(22): 2931-2932.
[17] Mahfouz M M, Li L, Shamimuzzaman M, et al. De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks. Proc Natl Acad Sci USA, 2011, 108(6): 2623-2628.
[18] 沈延,肖安,黄鹏,等.类转录激活因子效应物核酸酶 (TALEN) 介导的基因组定点修饰技术. 遗传, 2013, 35(4): 395-409. Shen Y, Xiao A, Huang P, et al. TALE nuclease engineering and targeted genome modification. HEREDITAS (Beijing), 2013, 35(4):395-409.
[19] Liu J, Gaj T, Patterson J T, et al. Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering. PloS one, 2014, 9(1): e85755.
[20] Jia J, Jin Y, Bian T, et al. Bacterial Delivery of TALEN Proteins for Human Genome Editing. PloS one, 2014, 9(3): e91547.
[21] Bichsel C, Neeld D K, Hamazaki T, et al. Bacterial delivery of nuclear proteins into pluripotent and differentiated cells. PloS one, 2011, 6(1): e16465.
[22] Bichsel C, Neeld D, Hamazaki T, et al. Direct Reprogramming of Fibroblasts to Myocytes via Bacterial Injection of MyoD Protein. Cell Reprogram, 2013, 15(2): 117-125.
[23] Sander J D, Cade L, Khayter C, et al. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat biotechnol, 2011, 29(8): 697-698.
[24] Hockemeyer D, Wang H, Kiani S, et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat biotechnol, 2011, 29(8): 731-734.
[25] Tesson L, Usal C, Ménoret S, et al. Knockout rats generated by embryo microinjection of TALENs. Nat biotechnol, 2011, 29(8): 695-696.
[26] Hockemeyer D, Soldner F, Beard C, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat biotechnol, 2009, 27(9): 851-857.
[27] Piganeau M, Ghezraoui H, De Cian A, et al. Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res, 2013, 23(7): 1182-1193.
[28] Sun N, Zhao H. Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs. Biotechnol Bioeng, 2014, 111(5): 1048-1053.
[29] Ma N, Liao B, Zhang H, Wang L, Shan Y, Xue Y, et al. TALEN-mediated gene correction in integration-free beta-thalassemia iPSCs. J Biol Chem, 2013, 288(48): 34671-34679.
[30] Seth A, Stemple D L, Barroso I. The emerging use of zebrafish to model metabolic disease. Dis Model Mech, 2013, 6(5): 1080-1088.
[31] Osborn M J, Starker C G, McElroy A N, et al. TALEN-based gene correction for epidermolysis bullosa. Mol Ther, 2013, 21(6): 1151-1159.
[32] Hu R, Wallace J, Dahlem T J, et al. Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs). PloS one, 2013, 8(5): e63074.
[33] Bacman S R, Williams S L, Pinto M, et al. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat med, 2013, 19(9): 1111-1113.
[34] Manjunath N, Yi G, Dang Y, et al. Newer Gene Editing Technologies toward HIV Gene Therapy. Viruses, 2013, 5(11): 2748-2766.
[35] Moghaddassi S, Eyestone W, Bishop C E. TALEN-mediated modification of the bovine genome for Large-Scale production of Human serum albumin. PloS one, 2014, 9(2): e89631.
|
